BMS-话题@MedSci - 梅斯（MedSci）

#BMS#

60篇内容 | 2083人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1378671, encodeId=f06413e86711e, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=BMS公布CheckMate 227临床研究第1部分最终结果：O药联合低剂量伊匹木单抗用于治疗NSCLC患者总生存获益显著优于化疗, objectType=article, longId=180256, objectId=d2b81802562b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2b81802562b, replyNumber=0, likeNumber=69, createdTime=2019-10-01, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2b81802562b, moduleTitle=BMS公布CheckMate 227临床研究第1部分最终结果：O药联合低剂量伊匹木单抗用于治疗NSCLC患者总生存获益显著优于化疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d2b81802562b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378670, encodeId=c30313e867019, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=BMS的PD-1单抗Opdivo：未能在III期临床改善多形性胶质母细胞瘤患者的无进展生存期, objectType=article, longId=178992, objectId=cb1b1e899242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb1b1e899242, replyNumber=0, likeNumber=59, createdTime=2019-09-07, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb1b1e899242, moduleTitle=BMS的PD-1单抗Opdivo：未能在III期临床改善多形性胶质母细胞瘤患者的无进展生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cb1b1e899242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378669, encodeId=cd3513e8669d4, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=BMS的PD-1单抗联合CTLA-4单抗治疗肝细胞癌的早期临床结果很有前景, objectType=article, longId=167676, objectId=769c16e676a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=769c16e676a7, replyNumber=0, likeNumber=101, createdTime=2019-06-06, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=769c16e676a7, moduleTitle=BMS的PD-1单抗联合CTLA-4单抗治疗肝细胞癌的早期临床结果很有前景, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=769c16e676a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378668, encodeId=b63c13e8668b7, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=IUBMB Life:HAMSCs / HBMSCs transwell和混合共培养系统的成骨效果对比, objectType=article, longId=166788, objectId=8a19166e88c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a19166e88c6, replyNumber=0, likeNumber=72, createdTime=2019-05-27, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a19166e88c6, moduleTitle=IUBMB Life:HAMSCs / HBMSCs transwell和混合共培养系统的成骨效果对比, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8a19166e88c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378667, encodeId=e76513e8667ee, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Mol Med Rep：P物质通过自噬激活增强BMSC成骨分化, objectType=article, longId=166770, objectId=d725166e701e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d725166e701e, replyNumber=0, likeNumber=63, createdTime=2019-05-26, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d725166e701e, moduleTitle=Mol Med Rep：P物质通过自噬激活增强BMSC成骨分化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d725166e701e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378666, encodeId=a14f13e8666b2, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Am J Transl Res：低剂量tubacin通过ERK途径促进BMSCs增殖和形态学变化, objectType=article, longId=165110, objectId=9c7f165110c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c7f165110c6, replyNumber=0, likeNumber=64, createdTime=2019-04-29, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c7f165110c6, moduleTitle=Am J Transl Res：低剂量tubacin通过ERK途径促进BMSCs增殖和形态学变化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9c7f165110c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378665, encodeId=30bc13e866550, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Aging Cell：衰老BMSCs的MicroRNA-31a-5p与老年骨髓微环境中的骨形成和再吸收有关, objectType=article, longId=165094, objectId=88591650946e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88591650946e, replyNumber=0, likeNumber=54, createdTime=2019-04-29, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88591650946e, moduleTitle=Aging Cell：衰老BMSCs的MicroRNA-31a-5p与老年骨髓微环境中的骨形成和再吸收有关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=88591650946e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378664, encodeId=2bbe13e866482, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=J Cell Mol Med：MicroRNA-99a是KDM6B介导的BMSCs成骨分化的新型调节剂, objectType=article, longId=165089, objectId=48a516508984, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48a516508984, replyNumber=0, likeNumber=69, createdTime=2019-04-29, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48a516508984, moduleTitle=J Cell Mol Med：MicroRNA-99a是KDM6B介导的BMSCs成骨分化的新型调节剂, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=48a516508984)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378663, encodeId=308d13e866341, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=英国NICE批准BMS的肾癌免疫治疗组合：PD-1 单抗Opdivo和CTLA-4 单抗Yervoy, objectType=article, longId=163715, objectId=a607163e15bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a607163e15bb, replyNumber=0, likeNumber=60, createdTime=2019-04-07, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a607163e15bb, moduleTitle=英国NICE批准BMS的肾癌免疫治疗组合：PD-1 单抗Opdivo和CTLA-4 单抗Yervoy, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a607163e15bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378662, encodeId=3e9713e866259, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, objectType=article, longId=159002, objectId=515c159002e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515c159002e4, replyNumber=0, likeNumber=60, createdTime=2019-01-28, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515c159002e4, moduleTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=515c159002e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378661, encodeId=129913e866138, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Tissue Eng Part A：羟基磷灰石/胶原蛋白3D打印支架及其对hBMSCs的成骨作用, objectType=article, longId=158941, objectId=2ff015894135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ff015894135, replyNumber=0, likeNumber=54, createdTime=2019-01-27, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ff015894135, moduleTitle=Tissue Eng Part A：羟基磷灰石/胶原蛋白3D打印支架及其对hBMSCs的成骨作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2ff015894135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378660, encodeId=f65113e8660c1, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=J Cell Physiol：受体活性修饰蛋白1通过Hippo/Yap通路调节BMSCs的表型表达, objectType=article, longId=157772, objectId=84a415e7726a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84a415e7726a, replyNumber=0, likeNumber=59, createdTime=2019-01-12, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84a415e7726a, moduleTitle=J Cell Physiol：受体活性修饰蛋白1通过Hippo/Yap通路调节BMSCs的表型表达, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=84a415e7726a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378659, encodeId=bafd13e86591a, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Arch Oral Biol：Runx1通过Wnt/β-catenin通路抑制脂肪形成，调节BMSCs的成骨分化, objectType=article, longId=153086, objectId=a5771530869f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5771530869f, replyNumber=0, likeNumber=68, createdTime=2018-11-10, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5771530869f, moduleTitle=Arch Oral Biol：Runx1通过Wnt/β-catenin通路抑制脂肪形成，调节BMSCs的成骨分化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a5771530869f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378658, encodeId=257113e8658cd, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Am J Transl Res：E7肽功能化Ti6Al4V合金可有效促进BMSCs的富集, objectType=article, longId=151350, objectId=995315135069, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=995315135069, replyNumber=0, likeNumber=63, createdTime=2018-10-20, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=995315135069, moduleTitle=Am J Transl Res：E7肽功能化Ti6Al4V合金可有效促进BMSCs的富集, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=995315135069)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378657, encodeId=e1e113e86571d, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Exp Cell Res：LL-37抑制LPS诱导的炎症并通过P2X7受体和MAPK信号通路刺激BMSCs的成骨分化, objectType=article, longId=150483, objectId=5dd815048370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dd815048370, replyNumber=0, likeNumber=73, createdTime=2018-10-08, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dd815048370, moduleTitle=Exp Cell Res：LL-37抑制LPS诱导的炎症并通过P2X7受体和MAPK信号通路刺激BMSCs的成骨分化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5dd815048370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378656, encodeId=4e7313e8656e0, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Biochimie：HAMSCs/HBMSCs共培养系统改善骨生成和血管生成以抵抗糖脂毒性, objectType=article, longId=146846, objectId=9fc214684689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fc214684689, replyNumber=0, likeNumber=58, createdTime=2018-08-18, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fc214684689, moduleTitle=Biochimie：HAMSCs/HBMSCs共培养系统改善骨生成和血管生成以抵抗糖脂毒性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9fc214684689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378655, encodeId=9fe713e865519, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=BMS的PD-1明星单抗Opdivo引领其第二季度销售额达57亿美元, objectType=article, longId=145300, objectId=2ce11453002a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ce11453002a, replyNumber=0, likeNumber=75, createdTime=2018-07-29, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ce11453002a, moduleTitle=BMS的PD-1明星单抗Opdivo引领其第二季度销售额达57亿美元, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2ce11453002a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378654, encodeId=412d13e865401, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Cell Physiol Biochem：FGF-2基因过表达慢病毒转染BMSCs联合异种抗原提取松质骨可有效治疗缺血性骨坏死, objectType=article, longId=144868, objectId=6b08144868a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b08144868a1, replyNumber=0, likeNumber=61, createdTime=2018-07-22, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b08144868a1, moduleTitle=Cell Physiol Biochem：FGF-2基因过表达慢病毒转染BMSCs联合异种抗原提取松质骨可有效治疗缺血性骨坏死, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6b08144868a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378653, encodeId=c2be13e865375, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=Cell Physiol Biochem：IL-8通过CXCR2介导的PI3k/Akt信号通路增强BMSCs的骨再生作用, objectType=article, longId=144753, objectId=3bf1144e5387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bf1144e5387, replyNumber=0, likeNumber=64, createdTime=2018-07-21, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bf1144e5387, moduleTitle=Cell Physiol Biochem：IL-8通过CXCR2介导的PI3k/Akt信号通路增强BMSCs的骨再生作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3bf1144e5387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378652, encodeId=3ada13e8652c0, content=<a href='/topic/show?id=f238358866' target=_blank style='color:#2F92EE;'>#BMS#</a>, objectTitle=BMS的Opdivo / Yervoy组合治疗肺癌申请通过, objectType=article, longId=141390, objectId=e14c141390a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e14c141390a6, replyNumber=0, likeNumber=87, createdTime=2018-06-24, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e14c141390a6, moduleTitle=BMS的Opdivo / Yervoy组合治疗肺癌申请通过, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e14c141390a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

BMS

2020-05-29

canlab (审核中...)

前往app查看评论内容

#BMS#

BMS公布CheckMate 227临床研究第1部分最终结果：O药联合低剂量伊匹木单抗用于治疗NSCLC患者总生存获益显著优于化疗

2019-10-01

canlab (审核中...)

前往app查看评论内容

#BMS#

BMS的PD-1单抗Opdivo：未能在III期临床改善多形性胶质母细胞瘤患者的无进展生存期

2019-09-07

canlab (审核中...)

前往app查看评论内容

#BMS#

BMS的PD-1单抗联合CTLA-4单抗治疗肝细胞癌的早期临床结果很有前景

2019-06-06

canlab (审核中...)

前往app查看评论内容

#BMS#

IUBMB Life:HAMSCs / HBMSCs transwell和混合共培养系统的成骨效果对比

2019-05-27

canlab (审核中...)

前往app查看评论内容

#BMS#

Mol Med Rep：P物质通过自噬激活增强BMSC成骨分化

2019-05-26

canlab (审核中...)

前往app查看评论内容

#BMS#

Am J Transl Res：低剂量tubacin通过ERK途径促进BMSCs增殖和形态学变化

2019-04-29

canlab (审核中...)

前往app查看评论内容

#BMS#

Aging Cell：衰老BMSCs的MicroRNA-31a-5p与老年骨髓微环境中的骨形成和再吸收有关

2019-04-29

canlab (审核中...)

前往app查看评论内容

#BMS#

J Cell Mol Med：MicroRNA-99a是KDM6B介导的BMSCs成骨分化的新型调节剂

2019-04-29

canlab (审核中...)

前往app查看评论内容

#BMS#

英国NICE批准BMS的肾癌免疫治疗组合：PD-1 单抗Opdivo和CTLA-4 单抗Yervoy

2019-04-07

canlab (审核中...)

前往app查看评论内容

#BMS#

Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症

2019-01-28

canlab (审核中...)

前往app查看评论内容

#BMS#

Tissue Eng Part A：羟基磷灰石/胶原蛋白3D打印支架及其对hBMSCs的成骨作用

2019-01-27

canlab (审核中...)

前往app查看评论内容

#BMS#

J Cell Physiol：受体活性修饰蛋白1通过Hippo/Yap通路调节BMSCs的表型表达

2019-01-12

canlab (审核中...)

前往app查看评论内容

#BMS#

Arch Oral Biol：Runx1通过Wnt/β-catenin通路抑制脂肪形成，调节BMSCs的成骨分化

2018-11-10

canlab (审核中...)

前往app查看评论内容

#BMS#

Am J Transl Res：E7肽功能化Ti6Al4V合金可有效促进BMSCs的富集

2018-10-20

canlab (审核中...)

前往app查看评论内容

#BMS#

Exp Cell Res：LL-37抑制LPS诱导的炎症并通过P2X7受体和MAPK信号通路刺激BMSCs的成骨分化

2018-10-08

canlab (审核中...)

前往app查看评论内容

#BMS#

Biochimie：HAMSCs/HBMSCs共培养系统改善骨生成和血管生成以抵抗糖脂毒性

2018-08-18

canlab (审核中...)

前往app查看评论内容

#BMS#

BMS的PD-1明星单抗Opdivo引领其第二季度销售额达57亿美元

2018-07-29

canlab (审核中...)

前往app查看评论内容

#BMS#

Cell Physiol Biochem：FGF-2基因过表达慢病毒转染BMSCs联合异种抗原提取松质骨可有效治疗缺血性骨坏死

2018-07-22

canlab (审核中...)

前往app查看评论内容

#BMS#

Cell Physiol Biochem：IL-8通过CXCR2介导的PI3k/Akt信号通路增强BMSCs的骨再生作用

2018-07-21

canlab (审核中...)

前往app查看评论内容

#BMS#

BMS的Opdivo / Yervoy组合治疗肺癌申请通过

2018-06-24

科室
- - 订阅+
  - 更多科室
工具
服务